IQuity Wins $320k NIH Grant to Develop Alzheimer’s Diagnostic Tech

“IQuity’s advances in RNA testing and data science have potential to create predictive diagnostic tools that will lead to an earlier diagnosis of Alzheimer’s,” Iquity CEO Chase Spurlock said in a statement. “New therapies that emerge for Alzheimer’s will be most effective when administered early, which is difficult with today’s diagnostic approach.”

Similar Posts

Leave a Reply

Your email address will not be published.